1. Home
  2. MDGL vs GMED Comparison

MDGL vs GMED Comparison

Compare MDGL & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

SELL

Current Price

$459.63

Market Cap

11.5B

Sector

Health Care

ML Signal

SELL

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

SELL

Current Price

$79.00

Market Cap

11.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MDGL
GMED
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
11.0B
IPO Year
2005
2012

Fundamental Metrics

Financial Performance
Metric
MDGL
GMED
Price
$459.63
$79.00
Analyst Decision
Strong Buy
Buy
Analyst Count
19
15
Target Price
★ $685.78
$100.92
AVG Volume (30 Days)
254.0K
★ 1.4M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 422.67
EPS
N/A
★ 2.00
Revenue
$180,133,000.00
★ $2,938,931,000.00
Revenue This Year
$59.57
$8.87
Revenue Next Year
$38.84
$6.04
P/E Ratio
★ N/A
$38.19
Revenue Growth
N/A
★ 16.65
52 Week Low
$393.61
$58.51
52 Week High
$615.00
$101.40

Technical Indicators

Market Signals
Indicator
MDGL
GMED
Relative Strength Index (RSI) 29.26 60.51
Support Level $455.42 $73.68
Resistance Level $546.29 $82.23
Average True Range (ATR) 16.54 1.70
MACD -4.18 0.58
Stochastic Oscillator 17.12 95.99

Price Performance

Historical Comparison
MDGL
GMED

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Share on Social Networks: